Compounds > iopamidol
Page last updated: 2024-08-24

iopamidol and Inflammation

iopamidol has been researched along with Inflammation in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Berg, P; Flüh, C; Hille, G; Jansen, O; Larsen, N; Saalfeld, S; Synowitz, M; Trick, D; Voß, S; Wodarg, F1
Cheng, JJ; Hou, WS; Wu, HW; Xu, JR; Yin, Y; Zhang, Q1
Aikawa, E; Figueiredo, JL; Hembrador, S; Keliher, E; Kelly, K; Libby, P; Nahrendorf, M; Panizzi, P; Weissleder, R; Zhang, H1
Brady, TJ; Cury, RC; Figueroa, AL; Gardecki, JA; Hoffmann, U; Subramanian, SS; Tawakol, A; Tearney, GJ; Truong, QA1
Chevrot, A; Lillo-Le Louët, A; Scotté, F; Wyplosz, B1
Bubberman, A; Ginai, AZ; Morcos, SK; Van Leeuwen, W; Zondervan, PE1

Other Studies

6 other study(ies) available for iopamidol and Inflammation

ArticleYear
Multimodal validation of focal enhancement in intracranial aneurysms as a surrogate marker for aneurysm instability.
    Neuroradiology, 2020, Volume: 62, Issue:12

    Topics: Aged; Aged, 80 and over; Aneurysm, Ruptured; Angiography, Digital Subtraction; Biomarkers; Contrast Media; Female; Hemodynamics; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Inflammation; Intracranial Aneurysm; Iopamidol; Magnetic Resonance Angiography; Male; Middle Aged; Risk Factors

2020
Differentiation of lung cancers from inflammatory masses with dual-energy spectral CT imaging.
    Academic radiology, 2015, Volume: 22, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Female; Humans; Inflammation; Iopamidol; Lung; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Observer Variation; Radiographic Image Enhancement; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed

2015
18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.
    JACC. Cardiovascular imaging, 2009, Volume: 2, Issue:10

    Topics: Animals; Apolipoproteins E; Atherosclerosis; Atorvastatin; Binding, Competitive; Cells, Cultured; Contrast Media; Disease Models, Animal; Endothelium, Vascular; Feasibility Studies; Fluorodeoxyglucose F18; Graft Rejection; Half-Life; Heart Transplantation; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Iopamidol; Ligands; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Peptides; Positron-Emission Tomography; Predictive Value of Tests; Pyrroles; Radiopharmaceuticals; Reproducibility of Results; RNA, Messenger; Tissue Distribution; Tomography, X-Ray Computed; Vascular Cell Adhesion Molecule-1

2009
Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology.
    Circulation. Cardiovascular imaging, 2012, Volume: 5, Issue:1

    Topics: Aged; Atherosclerosis; Carotid Stenosis; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Iopamidol; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed

2012
Recurrent iodide mumps after repeated administration of contrast media.
    Annals of internal medicine, 2006, Jul-18, Volume: 145, Issue:2

    Topics: Contrast Media; Edema; Humans; Inflammation; Injections, Intravenous; Iopamidol; Male; Middle Aged; Recurrence; Submandibular Gland

2006
The histological response of the lungs of rats to potentially suitable water soluble bronchographic contrast agents iotrolan (a non-ionic dimer) and iopamidol (a non-ionic monomer).
    The British journal of radiology, 1993, Volume: 66, Issue:789

    Topics: Animals; Bronchi; Contrast Media; Inflammation; Iopamidol; Lung; Male; Radiography; Rats; Rats, Wistar; Triiodobenzoic Acids

1993